• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

View 1: should this patient receive laser treatment?

作者信息

Dowler J

机构信息

Moorfields Eye Hospital, City Road, London EC1V 2RD, UK.

出版信息

Br J Ophthalmol. 2004 Mar;88(3):433-5. doi: 10.1136/bjo.2003.024752a.

DOI:10.1136/bjo.2003.024752a
PMID:14977784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1772048/
Abstract
摘要

相似文献

1
View 1: should this patient receive laser treatment?观点1：该患者应接受激光治疗吗？
Br J Ophthalmol. 2004 Mar;88(3):433-5. doi: 10.1136/bjo.2003.024752a.
2
View 2: should this patient receive laser treatment?观点2：该患者应接受激光治疗吗？
Br J Ophthalmol. 2004 Mar;88(3):435-6. doi: 10.1136/bjo.2003.024760a.
3
Diabetic retinopathy: should this patient receive laser treatment? Overview.糖尿病视网膜病变：该患者是否应接受激光治疗？概述。
Br J Ophthalmol. 2004 Mar;88(3):436-7. doi: 10.1136/bjo.2003.024760.
4
Diabetic retinopathy: should this patient receive laser treatment?糖尿病性视网膜病变：该患者是否应接受激光治疗？
Br J Ophthalmol. 2004 Mar;88(3):433. doi: 10.1136/bjo.2003.024752.
5
Progress report on cases of proliferative diabetic retinopathy treated with light coagulation. (Four-year follow-up).
Trans Ophthalmol Soc U K (1962). 1969;88:741-9.
6
[Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].[2型糖尿病并发症糖尿病性视网膜病变患者的激光光凝治疗结果]
Klin Oczna. 2006;108(1-3):66-9.
7
Giant retinal pigment epithelial tear after laser photocoagulation for diabetic retinopathy.糖尿病性视网膜病变激光光凝术后的巨大视网膜色素上皮撕裂
Br J Ophthalmol. 2009 Jan;93(1):11-2, 123. doi: 10.1136/bjo.2007.130849.
8
Laser photocoagulation of diabetic macular edema.
Ophthalmic Surg Lasers. 1997 May;28(5):387-408.
9
Sequelae to preretinal haemorrhage in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中视网膜前出血的后遗症。
Br J Ophthalmol. 1969 Sep;53(9):627-9. doi: 10.1136/bjo.53.9.627.
10
[Substance analytic studies of the effectiveness of laser coagulation in diabetic retinopathy].[糖尿病视网膜病变激光凝固术有效性的物质分析研究]
Ophthalmologe. 1993 Oct;90(5):452-6.

本文引用的文献

1
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较（英国前瞻性糖尿病研究[UKPDS 33]）。英国前瞻性糖尿病研究（UKPDS）小组
Lancet. 1998 Sep 12;352(9131):837-53.
2
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.2型糖尿病患者严格血压控制与大血管及微血管并发症风险：英国前瞻性糖尿病研究（UKPDS 38）。英国前瞻性糖尿病研究小组
BMJ. 1998 Sep 12;317(7160):703-13.
3
Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.糖尿病视网膜病变中血清脂质水平升高与视网膜硬性渗出的关联。早期治疗糖尿病视网膜病变研究（ETDRS）报告22
Arch Ophthalmol. 1996 Sep;114(9):1079-84. doi: 10.1001/archopht.1996.01100140281004.
4
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.威斯康星糖尿病视网膜病变流行病学研究。III. 诊断时年龄为30岁及以上者糖尿病视网膜病变的患病率和风险。
Arch Ophthalmol. 1984 Apr;102(4):527-32. doi: 10.1001/archopht.1984.01040030405011.
5
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.威斯康星糖尿病视网膜病变流行病学研究。II. 诊断时年龄小于30岁的糖尿病视网膜病变患病率及风险
Arch Ophthalmol. 1984 Apr;102(4):520-6. doi: 10.1001/archopht.1984.01040030398010.
6
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.糖尿病视网膜病变进展的眼底照相危险因素。ETDRS报告第12号。早期治疗糖尿病视网膜病变研究组。
Ophthalmology. 1991 May;98(5 Suppl):823-33.